North America Diabetes Devices Market worth $28.50 billion by 2033 - Exclusive Report by DatamIntelligence

"The North America Diabetes Devices market size reached US$ 13.76 Billion in 2024 and is expected to reach US$ 28.50 Billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/north-america-diabetes-devices-market?sp

United States: Recent Industry Developments

✅ In October 2025, Medtronic launched its next-generation MiniMed 780G insulin pump system in the U.S., featuring advanced automated insulin delivery and continuous glucose monitoring integration to improve glycemic control in patients with type 1 diabetes.

✅ In September 2025, Dexcom received FDA approval for its G7 continuous glucose monitoring system, offering a smaller, more accurate, and faster-responding device. The launch is expected to enhance diabetes management for millions of U.S. patients.

✅ In August 2025, Abbott expanded its FreeStyle Libre product line with new wearable sensors designed for longer wear time and improved accuracy, aiming to simplify glucose monitoring for patients with type 2 diabetes.

✅ In July 2025, the American Diabetes Association highlighted the growing adoption of digital diabetes devices, reporting that integration of continuous glucose monitors and insulin pumps significantly improves patient adherence and outcomes.

Canada: Recent Industry Developments

✅ In October 2025, Health Canada approved Medtronic's MiniMed 780G system, allowing Canadian patients with type 1 diabetes to access advanced automated insulin delivery technology.

✅ In September 2025, Dexcom G7 continuous glucose monitoring system received regulatory approval in Canada, offering patients enhanced accuracy and a simplified user experience for glucose management.

✅ In August 2025, Abbott launched updated FreeStyle Libre sensors in Canada, supporting extended wear and better glucose tracking for type 2 diabetes patients.

✅ In July 2025, the Canadian Diabetes Association emphasized the benefits of digital diabetes devices, encouraging wider adoption to improve patient outcomes and reduce long-term complications.

North America Diabetes Devices Market: Drivers

The North America diabetes devices market is witnessing robust growth, driven by increasing prevalence of diabetes, rising awareness of disease management, and growing demand for advanced monitoring and insulin delivery solutions. Diabetes devices, including glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, and smart pens, are essential for maintaining glycemic control, preventing complications, and improving quality of life. Advances in wearable technology, AI-enabled monitoring, and integrated mobile health platforms are enhancing accuracy, real-time data insights, and patient engagement. Expansion of healthcare infrastructure, diabetes care programs, and insurance coverage is further supporting market adoption. Growing patient preference for minimally invasive, user-friendly, and connected devices is boosting demand across the region.

Leading companies, including Abbott Laboratories, Medtronic, Dexcom, and Roche Diabetes Care, are developing innovative diabetes devices with improved accuracy, connectivity, and automated insulin delivery capabilities. Research into non-invasive glucose monitoring, AI-driven predictive analytics, and closed-loop insulin systems is expanding clinical options and patient adherence. Strategic collaborations between device manufacturers, healthcare providers, and digital health platforms are accelerating product development, commercialization, and adoption. Increasing focus on preventive care, patient-centric management, and chronic disease monitoring is driving market growth. With continuous technological innovation, rising diabetes prevalence, and expanding healthcare access, the North America diabetes devices market is poised for sustained growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/north-america-diabetes-devices-market?sp

North America Diabetes Devices Market: Major Players

Johnson & Johnson Services, Inc., Abbott, Dexcom Inc, Tandem Diabetes Care, Inc., LifeScan IP Holdings, LLC., Medtronic, Insulet Corporation, F. Hoffmann-La Roche AG, ACON Laboratories, Inc., Novo Nordisk A/S., among others.

Segment Covered in the North America Diabetes Devices Market:

➥ By Device Type: Blood Glucose Monitoring (BGM) Devices, Management Devices, Others

➥ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, Others

Research Process:

Both primary and secondary data sources have been used in the North America Diabetes Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the North America Diabetes Devices Market Research Industry:

➠ Who leads the North America Diabetes Devices industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do North America Diabetes Devices market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting North America Diabetes Devices market growth?
➠ What are the dominant sales and distribution strategies in the North America Diabetes Devices industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=north-america-diabetes-devices-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.